Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.17 - $1.94 $477 - $791
-408 Reduced 57.46%
302 $0
Q4 2023

Feb 14, 2024

BUY
$1.02 - $1.47 $724 - $1,043
710 New
710 $0
Q3 2021

Nov 04, 2021

SELL
$2.35 - $3.16 $58,825 - $79,101
-25,032 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$2.91 - $3.83 $1,713 - $2,255
589 Added 2.41%
25,032 $78,000
Q1 2021

May 13, 2021

SELL
$3.47 - $4.75 $25,900 - $35,454
-7,464 Reduced 23.39%
24,443 $90,000
Q4 2020

Feb 16, 2021

SELL
$3.2 - $4.98 $41,238 - $64,177
-12,887 Reduced 28.77%
31,907 $132,000
Q3 2020

Nov 12, 2020

BUY
$3.69 - $7.09 $31,324 - $60,187
8,489 Added 23.38%
44,794 $175,000
Q2 2020

Aug 13, 2020

BUY
$3.58 - $7.44 $30,043 - $62,436
8,392 Added 30.06%
36,305 $271,000
Q1 2020

May 14, 2020

SELL
$3.49 - $9.2 $150,698 - $397,255
-43,180 Reduced 60.74%
27,913 $125,000
Q4 2019

Feb 14, 2020

BUY
$6.27 - $11.41 $401,812 - $731,209
64,085 Added 914.45%
71,093 $654,000
Q3 2019

Nov 14, 2019

SELL
$4.75 - $8.38 $2,612 - $4,609
-550 Reduced 7.28%
7,008 $48,000
Q2 2019

Aug 14, 2019

SELL
$6.4 - $10.94 $90,016 - $153,871
-14,065 Reduced 65.05%
7,558 $52,000
Q1 2019

May 15, 2019

BUY
$6.1 - $10.3 $3,477 - $5,871
570 Added 2.71%
21,623 $220,000
Q4 2018

Feb 14, 2019

SELL
$5.84 - $11.92 $138,063 - $281,800
-23,641 Reduced 52.9%
21,053 $130,000
Q3 2018

Dec 21, 2021

BUY
$12.43 - $29.76 $62,759 - $150,258
5,049 Added 12.74%
44,694 $555,000
Q3 2018

Nov 14, 2018

BUY
$12.43 - $29.76 $103,032 - $246,680
8,289 Added 26.44%
39,645 $492,000
Q2 2018

Apr 21, 2020

BUY
$18.75 - $28.46 $107,775 - $163,588
5,748 Added 22.45%
31,356 $877,000
Q2 2018

Aug 14, 2018

BUY
$18.75 - $28.46 $347,531 - $527,506
18,535 Added 262.05%
25,608 $716,000
Q1 2018

Oct 18, 2019

BUY
$15.91 - $20.82 $19,792 - $25,900
1,244 Added 21.34%
7,073 $140,000
Q1 2018

May 15, 2018

SELL
$15.91 - $20.82 $116,381 - $152,298
-7,315 Reduced 55.65%
5,829 $115,000
Q4 2017

Feb 14, 2018

BUY
$15.2 - $20.76 $199,788 - $272,869
13,144
13,144 $247,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $42.5M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.